Retinal Microaneurysm Counts and 10-Year Progression of Diabetic Retinopathy
Ronald Klein, MD;
Stacy M. Meuer;
Scot E. Moss, MA;
Barbara E. K. Klein, MD
Arch Ophthalmol. 1995;113(11):1386-1391.
Abstract
| |
Objective
To determine the relationship of change in the number of retinal microaneurysms to the 10-year progression to significant retinopathy, proliferative retinopathy, and clinically significant macular edema.
Design
Population-based study of persons with youngerand older-onset diabetes with 10 years of follow-up.
Setting and Patients
Eleven-county area in southern Wisconsin, where 189 patients with diabetes who had only retinal microaneurysms in photographs at baseline participated in 4- and 10-year follow-up examinations.
Outcome Measures
Ten-year incidence of moderate nonproliferative diabetic retinopathy or worse, proliferative retinopathy, or clinically significant macular edema as determined by masked grading of stereoscopic color fundus photographs of seven standard fields.
Results
The increase in the number of retinal microaneurysms and the ratio of the number of retinal microaneurysms at the 4-year follow-up to the number at baseline were positively associated with incidence of proliferative retinopathy or clinically significant macular edema at the 10-year follow-up. Proliferative retinopathy was approximately 4.6 times and clinically significant macular edema was approximately 9.1 times more likely to develop at 10-year follow-up in eyes in which the number of microaneurysms increased by 16 or more from baseline to the 4-year follow-up than in eyes with no increase. Proliferative retinopathy was 3.4 times and clinically significant macular edema was 6.7 times more likely to develop at 10-year follow-up in eyes that had ratios of 3 or greater of the number of retinal microaneurysms at the 4-year follow-up to the number at baseline than in eyes in which the ratios were smaller. These relationships remained after controlling for the level of glycosylated hemoglobin and type of diabetes.
Conclusions
Microaneurysm counts using stereoscopic color fundus photographs are an early important measure of progression of retinopathy and may serve as a surrogate end point for severe change in some clinical trials.
Author Affiliations
From the Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium
Csaky et al.
IOVS 2008;49:479-489.
FULL TEXT
Aspirin at Low-Intermediate Concentrations Protects Retinal Vessels in Experimental Diabetic Retinopathy Through Non-Platelet-Mediated Effects
Sun et al.
Diabetes 2005;54:3418-3426.
ABSTRACT
| FULL TEXT
Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research
Donnelly et al.
Br J Ophthalmol 2004;88:145-151.
ABSTRACT
| FULL TEXT
Automated Measurement of Microaneurysm Turnover
Goatman et al.
IOVS 2003;44:5335-5341.
ABSTRACT
| FULL TEXT
Review: Overview of diabetic eye disease
Leese and Ellis
British Journal of Diabetes & Vascular Disease 2002;2:14-17.
ABSTRACT
Treatment of Diabetic Retinopathy
Ferris et al.
NEJM 1999;341:667-678.
FULL TEXT
United Kingdom Prospective Diabetes Study, 30: Diabetic Retinopathy at Diagnosis of Non-Insulin-Dependent Diabetes Mellitus and Associated Risk Factors
Kohner et al.
Arch Ophthalmol 1998;116:297-303.
ABSTRACT
| FULL TEXT
|
